| Order No. |
Clone Name |
Specificity |
| 0801/SW480/Co |
|
0801/SW480/Co Cell lysate from untreated SW480 cells, colorectal adenocarcinoma (human) |
| 0802/SW480/VH |
|
0802/SW480/VH Cell lysate from pervanadate-treated SW480 cells, colorectal adenocarcinoma (human) |
| 0803/SW480/LiCl |
|
0803/SW480/LiCI Cell lysate from LiCl-treated SW480 cells, colorectal adenocarcinoma (human) |
| 0811/HepG2/Co |
|
0811/HepG2/Co Cell lysate from untreated HepG2 cells, hepatocellular carcinoma (human) |
| 0812/HepG2/VH |
|
0812/HepG2/VH Cell lysate from pervanadate-treated HepG2 cells, hepatocellular carcinoma (human) |
| 0813/HepG2/EGF |
|
0813/HepG2/EGF Cell lysate from EGF-treated HepG2 cells, hepatocellular carcinoma (human) |
| 0814/HepG2/Forskolin |
|
0814/HepG2/Forskolin Cell lysate from Forskolin-treated HepG2 cells, hepatocellular carcinoma (human) |
| 0815/HepG2/IL-4 |
|
0815/HepG2/IL-4 Cell lysate from IL-4-treated HepG2 cells, hepatocellular carcinoma (human) |
| 0816/HepG2shc/p66-IP |
|
0816/HepG2shc/p66-IP precipitated from EGF-treated HepG2 cells |
| 0817/HepG2/PMA+VH |
|
0817/HepG2/PMA+VH Cell lysate from PMA+pervanadate-treated HepG2 cells, hepatocellular carcinoma (human) |
| 0821/HeLa/Co |
|
0821/HeLa/Co Cell lysate from untreated HeLa cells, epitheloid cervical carcinoma (human) |
| 0822/HeLa/VH |
|
0822/HeLa/VH Cell lysate from pervanadate-treated HeLa cells, epitheloid cervical carcinoma (human) |
| 0831/A431/Co |
|
0831/A431/Co Cell lysate from untreated A431 cells, epidermoid carcinoma (human) |
| 0832/A431/VH |
|
0832/A431/VH Cell lysate from pervanadate-treated A431 cells, epidermoid carcinoma (human) |
| 0833/A431/PMA+VH |
|
0833/A431/PMA+VH Cell lysate from PMA+pervanadate-treated A431 cells, epidermoid carcinoma (human) |
| 0834/A431/Sorbit |
|
0834/A431/Sorbit Cell lysate from Sorbit-treated A431 cells, epidermoid carcinoma (human) |
| 0841/Jurkat/Co |
|
0841/Jurkat/Co Cell lysate from untreated Jurkat cells, T-cell leukemia (human) |
| 0842/Jurkat/VH |
|
0842/Jurkat/VH Cell lysate from pervanadate-treated Jurkat cells, T-cell leukemia (human) |
| 0851/THP-1/Co |
|
0851/THP-1/Co Cell lysate from untreated THP-1 cells, acute monocytic leukemia (human) |
| 0852/THP-1/VH |
|
0852/THP-1/VH Cell lysate from pervanadate-treated THP-1 cell, acute monocytic leukemia (human) |
| 0861/3T3/Co |
|
0861/3T3/Co Cell lysate from untreated NIH 3T3 cells, embryonic fibroblast (mouse) |
| 0862/3T3/VH |
|
0862/3T3/VH Cell lysate from pervanadate-treated NIH 3T3 cells |
| 0871/293/Co |
|
0871/293/Co Cell lysate from untreated HEK293 cells, human epithelial cell line (kidney) |
| 0872/293/VH |
|
0872/293/VH Cell lysate from pervanadate-treated HEK293 cells, human epithelial cell line (kidney) |
| 0873/293/Insulin |
|
0873/293/Insulin Cell lysate from Insulin-treated HEK293 cells, human epithelial cell line (kidney) |
| 0874/293/IGF1 |
|
0874/293/IGF1 Cell lysate from IGF1-treated HEK293 cells, human epithelial cell line (kidney) |
| 0881/MCF-7/Co |
|
0881/MCF-7/Co Cell lysate from untreated MCF-7 cells, breast adenocarcinoma (human) |
| 0882/MCF-7/VH |
|
0882/MCF-7/VH Cell lysate from pervanadate-treated MCF-7 cells, breast adenocarcinoma (human) |
| 0891/Bend3/Co |
|
0891/Bend3/Co Cell lysate from untreated Bend3 cells, brain endothelioma (mouse) |
| 0892/Bend3/VH |
|
0892/Bend3/VH Cell lysate from pervanadate-treated Bend3 cells, brain endothelioma (mouse) |
| 0901/PSERCO |
|
0901/PSERCO pSer/p Thr molecular weight marker, phosphoproteins from rabbit muscle |
| 0911/liquid/Neuro2A/Co |
|
0911/liquid/Neuro2A/Co Cell lysate from untreated Neuro2A, brain endothelioma (mouse); Formulation: liquid |
| 0911/Neuro2A/Co |
|
0911/Neuro2A/Co, Cell lysate from untreated Neuro2A cells, brain endothelioma (mouse) |
| 0912/Neuro2A/VH |
|
0912/Neuro2A/VH Cell lysate from pervanadate-treated Neuro2A cells, brain endothelioma (mouse) |
| 0921/K46/Co |
|
0921/K46/Co Cell lysate from untreated K46 cells, B-cell lymphoma (mouse) |
| 0922/K46/VH |
|
0922/K46/VH Cell lysate from pervanadate-treated K46 cells, B-cell lymphoma (mouse) |
| 0923/K46/PMA |
|
0923/K46/PMA Cell lysate from PMA-treated K46 cells, B-cell lymphoma (mouse) |
| 0931/PC12/Co |
|
0931/PC12/Co Cell lysate from untreated PC12 cells, adrenal pheochromocytoma (rat) |
| 0932/PC12/Sorbit |
|
0932/PC12/Sorbit Cell lysate from Sorbit-treated PC12 cells, adrenal pheochromocytoma (rat) |
| 0933/PC12/Forskolin |
|
0933/PC12/Forskolin Cell lysate from Forskolin-treated PC12 cells, adrenal pheochromocytoma (rat) |
| 0941/MDCK/Co |
|
0941/MDCK/Co Cell lysate from untreated MDCK cells, kidney carcinoma (dog) |
| 0942/MDCK/VH |
|
0942/MDCK/VH Cell lysate from pervanadate-treated MDCK cells, kidney carcinoma (dog) |
| 0961/SW620/Co |
|
0961/SW620/Co Cell lysate from untreated SW620 cells, colorectal adenocarcinoma (human) |
| 0962/SW620/VH |
|
0962/SW620/VH Cell lysate from pervanadate-treated SW620 cells, colorectal adenocarcinoma (human) |
| 0971/HT29/Co |
|
0971/HT29/Co Cell lysate from untreated HT 29 cells, colorectal adenocarcinoma (human) |
| 0981/10T1/2mCad |
|
0981/10T1/2mCad Cell lysate from 10T1/2 cells transfected with mCadherin, embryonic fibroblast (mouse) |
| 0991/SKOV3/Co |
|
0991/SKOV3/Co Cell lysate from untreated SKOV-3 cells, ovary adenocarcinoma (human) |
| 0992/SKOV3/VH |
|
0992/SKOV3/VH Cell lysate from pervanadate-treated SKOV-3 cells, ovary adenocarcinoma (human) |
| 0993/SKOV3/EGF |
|
0993/SKOV3/EGF Cell lysate from EGF-treated SKOV-3 cells, ovary adenocarcinoma (human) |
| 0994/SKOV3/PMA+VH |
|
0994/SKOV3/PMA+VH Cell lysate from PMA+pervanadate-treated SKOV-3 cells, ovary adenocarcinoma (human) |
| 0995/SKOV3/Fors.+IBMX |
|
0995/SKOV3/Fors.+IBMX Cell lysate from Forskolin+IBMX-treated SKOV-3 cells, ovary adenocarcinoma (human) |
| 1001/SH-SY5Y/Co |
|
1001/SH-SY5Y/Co Cell lysate from untreated SH-SY5Y cells, brain neuroblastoma (human) |
| 1002/SH-SY5Y/VH |
|
1002/SH-SY5Y/VH Cell lysate from pervanadate-treated SH-SY5Y cells, brain neuroblastoma (human) |
| 1001/SH-SY5Y/Co |
|
1001/SH-SY5Y/Co Cell lysate from untreated SH-SY5Y cells, brain neuroblastoma (human) |
| 1002/SH-SY5Y/VH |
|
1002/SH-SY5Y/VH Cell lysate from pervanadate-treated SH-SY5Y cells, brain neuroblastoma (human) |
| 1011/T47D/Co |
|
1011/T47D/Co Cell lysate from untreated T47D cells, ductal carcinoma (human) |
| 1012/T47D/VH |
|
1012/T47D/VH Cell lysate from pervanadate-treated T47D cells, ductal carcinoma (human) |
| 1021/MDA468/Co |
|
1021/MDA468/Co Cell lysate from untreated MDA-MB-468 cells, breast adenocarcinoma (human) |
| 1022/MDA468/VH |
|
1022/MDA468/VH Cell lysate from pervanadate-treated MDA-MB-468 cells, breast adenocarcinoma (human) |
| 1023/MDA468/EGF |
|
1023/MDA468/EGF Cell lysate from EGF-treated MDA-MB-468 cells, breast adenocarcinoma (human) |
| 1031/MDA231/Co |
|
1031/MDA231/Co Cell lysate from untreated MDA-MB-231 cells, breast adenocarcinoma (human) |
| 1032/MDA231/VH |
|
1032/MDA231/VH Cell lysate from pervanadate-treated MDA-MB-231 cells, breast adenocarcinoma (human) |
| 1033/MDA231/EGF |
|
1033/MDA231/EGF Cell lysate from EGF-treated MDA-MB-231 cells, breast adenocarcinoma (human) |
| 1041/PC3/LC3I |
|
1041/PC3/LC3I, 1041, PC3, LC3 I, cell fraction containing LC3 I was prepared from semiconfluent PC3 cells with LC3 I buffer |
Back to List